On Wednesday, Qualys, Inc. (NASDAQ:QLYS)’s shares gained 6.83%, and closed at $52.43, hitting new 52-week high of $52.96, after a pioneer and leading provider of cloud security and compliance solutions, declared that Qualys CEO Philippe Courtot will deliver the opening keynote presentation at CSA Summit during the RSA Conference 2015. The keynote discusses how the cloud has forced enterprises to consider adopting new and more advanced security standards to secure and maintain data sovereignty.
WHAT: Cloud Without Borders: Paving the Way for Global Security and Privacy
WHEN: Monday, April 20, 2015, 9:00-9:30 am PT
WHERE: Moscone West, Room 2014
WHO: Philippe Courtot, Chairman and Chief Executive Officer, Qualys.
Qualys, Inc. provides cloud security and compliance solutions in the United States and internationally. The corporation offers QualysGuard cloud suite of solutions, such as Vulnerability Administration, Policy Compliance, PCI Compliance, Web Application Scanning, Malware Detection Service, Web Application Firewall, and Qualys SECURE Seal
Geron Corporation (NASDAQ:GERN)’s shares jumped 6.38%, and settled at $4.00, during the last trading session on Wednesday, after a clinical stage biopharmaceutical corporation, declared that John Scarlett, M.D., President and Chief Executive Officer, will present an overview of the corporation at the 14th Annual Needham Healthcare Conference in New York. The presentation is planned to occur on Tuesday, April 14, at 5:00 p.m. Eastern Time.
Geron Corporation, a clinical stage biopharmaceutical corporation, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. It has partnershipand license contract with Janssen Biotech, Inc. to develop and commercialize imetelstat worldwide for indications in oncology, counting hematologic myeloid malignancies and other human therapeutic uses. The corporation was founded in 1990 and is based in Menlo Park, California.
At the end of Wednesday’s trade, Autohome Inc. (NYSE:ATHM)’s shares climbed 6.34%, and closed at $51.34, as on March 30, the leading online destination for automobile consumers in China, declared it filed its annual report on Form 20-F for the fiscal year ended December 31, 2014 with the Securities and Exchange Commission on March 27, 2015. The annual report on Form 20-F, which contains the Corporation’s audited merged financial statements, can be accessed on the SEC’s website at http://www.sec.gov in addition to through the Corporation’s investor relations website at http://ir.autohome.com.cn.
The Corporation will provide a hard copy of its annual report containing the audited merged financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to Investor Relations Department, Autohome Inc., 10th Floor Tower B, CEC Plaza, 3 Dan Ling Street, Haidian District, Beijing, People’s Republic of China.
Autohome Inc. operates as an online destination for automobile consumers in the People’s Republic of China. The corporation, through its Websites, autohome.com.cn and che168.com, delivers independent and interactive content to automobile buyers and owners, counting professionally produced content that comprises automobile-related articles and reviews, pricing trends in various markets, and photos and video clips; automobile library, which comprises a range of specifications covering performance levels, dimensions, powertrains, vehicle bodies, interiors, safety, entertainment systems, and other unique features, in addition to manufacturers suggested retail prices; new and used automobile listings, and promotional information; and user forums and user generated content.
Perseon Corporation (NASDAQ:PRSN), ended its Wednesday’s trading session with 6.06% gain, and closed at $0.35, after a life sciences corporation, declared that the corporation received clearance from the U.S. Food and Drug Administration (FDA) to market the MicroThermX(R) Microwave Ablation System (MicroThermX) for the specific indication of laparoscopic ablation procedures using image guidance.
“This new indication raises the type of cases that our technology will be used for and the opportunity to expand the use of MicroThermX in surgical oncology,” said Clint Carnell, CEO of Perseon. “This moves us closer to achieving our clinical initiatives to benefit patients, physicians, and the healthcare system worldwide.”
Perseon Corporation, a life sciences corporation, develops, manufactures, markets, and services medical systems to treat cancer and benign diseases using heat therapy. The corporation offers MicroThermX microwave ablation system that comprises a microwave generator, single-patient-use disposable antennas with cooling circuit, and a thermistor based temperature monitoring system; and employs precision-guided microwave energy to ablate diseased soft tissue.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
